CYP17A1 Antibody (D-12) is a high quality monoclonal CYP17A1 antibody (also designated CP17AC antibody, Cytochrome P450 Family 17 Subfamily A Member 1 antibody, Steroid 17-Alpha-Monooxygenase antibody, S17AH antibody, Cytochrome P450 Family 17 Subfamily A Polypeptide 1 antibody, 17-Alpha-Hydroxyprogesterone Aldolase antibody, CYPXVII antibody, CYP17 antibody, or CPT7 antibody) suitable for the detection of the CYP17A1 protein of human origin. CYP17A1 Antibody (D-12) is available as both the non-conjugated anti-CYP17A1 antibody form, as well as multiple conjugated forms of anti-CYP17A1 antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. P450 enzymes are classified into subfamilies, such as CYP1A, CYP2A, CYP2C, CYP2D, CYP4A14, CYP7A, CYP7B, CYP8B, CYP11A, CYP17A1, CYPI9 and CYP27A, based on sequence similarities. CYP17A (17alpha-hydroxylase/17,20-lyase) is important for the conversion of pregnenolone and progesterone to dehydroepiandrosterone (DHEA) and androstenedione. In this process, it catalyzes both the 17-alpha-hydroxylation and the 17,20-lyase reaction. CYP17A1 is crucial during sexual development, both during fetal development and during puberty, and is intracellularly regulated by cAMP levels. Defects in the CYP17A1 gene, which encodes for the protein, may cause adrenal hyperplasia type V (AH-V) which is characterized by hypokalemia and hypertension. Male patients affected by AH-V do not undergo normal sexual differentiation and develop female external genitalia and do not undergo pubertal develoment.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences